| Line Item | 2022-01-31 | Y/Y |
|---|---|---|
| Revenue | $204.8M | +120.1% |
| Cost of Revenue | $81.7M | +107.7% |
| Gross Profit | $123.1M | +129.2% |
| R&D Expense | $136.3M | +118.2% |
| SG&A Expense | $93.5M | +221.8% |
| Operating Income | -$267.2M | -131.3% |
| Interest Expense | $787K | -43.8% |
| Pre-tax Income | -$270.1M | -130.6% |
| Income Tax | $1.0M |
| Line Item | 2022-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.67B | +322.1% |
| Short-term Investments | $374K | +2.7% |
| Accounts Receivable | $101.5M | +158.1% |
| Current Assets | $1.82B | +291.7% |
| Total Assets | $2.04B | +292.3% |
| Current Liabilities | $281.3M | +118.2% |
| Long-term Debt | $0 | -100.0% |
| Line Item | 2022-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$95.6M | -43.6% |
| Capital Expenditures | $3.7M | +11.3% |
| Investing Cash Flow | -$19.7M | -215.1% |
| Financing Cash Flow | $1.39B | +227.2% |
| Free Cash Flow | -$99.2M | -42.1% |
| +118.3% |
| Net Income | -$271.1M | -130.6% |
| EPS (Basic) | -$1.56 | +52.9% |
| EPS (Diluted) | -$1.56 | +52.9% |
| Total Liabilities |
| $391.4M |
| +77.9% |
| Stockholders' Equity | $1.65B | +615.0% |